Zepp Health Q3 2025 Earnings Loss Per Share of 004 Amidst Market Challenges ASRT Q1 2026 Earnings Significant EPS Miss Amid Revenue Disclosure Absence EIKN Q1 2026 Earnings EPS Miss of 38 Amid PreRevenue Stage Stock Drops 9 Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses NEN Q4 2024 Earnings Partnership Reports 3612 EPS Amid Limited Disclosure OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline